Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference

Targeting metabolic reprogramming is an emerging strategy in cancer therapy. However, clinical attempts to target metabolic reprogramming have been proved to be challenging, with metabolic heterogeneity of cancer being one of many reasons that causes treatment failure. Here, we stratified non-small...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Kuo, Ting-Chun, Huang, Kuo-Yen, Yang, Shuenn-Chen, Wu, Sean, Chung, Wei-Chia, Chang, Yih-Leong, Hong, Tse-Ming, Wang, Shu-Ping, Chen, Hsuan-Yu, Hsiao, Tzu-Hung, Yang, Pan-Chyr
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364124/
https://ncbi.nlm.nih.gov/pubmed/32695876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.06.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados